Rapid Oral Fluid Screening Device Sales Are Extrapolated to Amass a Revenue of US$ 47.3 Billion by 2033

The global rapid oral fluid screening devices market accounts for a valuation of US$ 23.8 billion in 2023 and is forecasted to climb to US$ 47.3 billion by 2033-end. Fact.MR predicts global demand for rapid oral fluid screening devices to increase at a healthy 7.1% CAGR over the next ten years.

Download Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=2694

Rapid oral fluid screening devices allow a wide range of screening for the identification of drugs or other elements from oral samples. These devices are usually non-invasive in nature and this is a key aspect that is projected to uplift their demand throughout the forecast period and beyond.

Key Takeaways of Rapid Oral Fluid Screening Devices Market

• Increasing Demand for Non-Invasive Drug Testing: The rapid oral fluid screening devices market is experiencing significant growth due to the rising demand for non-invasive drug testing methods. Traditional drug testing methods often involve urine or blood samples, which can be invasive and time-consuming. Rapid oral fluid screening devices offer a convenient and non-invasive alternative, allowing for on-the-spot drug testing with quick and reliable results. These devices have gained popularity in various settings, including workplaces, law enforcement, and rehabilitation centers, contributing to the market's expansion.

• Stringent Regulations and Workplace Safety Requirements: Stringent regulations and workplace safety requirements are driving the adoption of rapid oral fluid screening devices. Many industries, such as transportation, construction have strict guidelines regarding drug testing to ensure the safety and well-being of employees and the public. Rapid oral fluid screening devices enable employers to conduct drug testing efficiently and effectively, helping them comply with regulatory standards and maintain a safe work environment.

• Advancements in Technology: Technological advancements have played a significant role in the growth of the rapid oral fluid screening devices market. Manufacturers are constantly innovating to improve the accuracy, sensitivity, and ease of use of these devices. The integration of advanced technologies, such as immunoassay-based testing, chromatography, and electrochemical sensing, has enhanced the performance and reliability of rapid oral fluid screening devices. These advancements have resulted in more accurate and rapid drug testing, boosting the market's demand.

• Increasing Substance Abuse Issues and Road Safety Concerns: The rising prevalence of substance abuse and the growing concerns about road safety have fueled the demand for rapid oral fluid screening devices. Drug-impaired driving is a significant issue globally, and law enforcement agencies are increasingly adopting rapid oral fluid screening devices to detect drug use in drivers quickly. Additionally, the opioid epidemic and the need for effective drug testing in rehabilitation centers and treatment facilities have contributed to the market's growth.

Get Customization on this Report for Specific Research Solutions:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=2694

Competitive Landscape

Leading rapid oral fluid screening device manufacturers are investing in research to develop and launch novel testing kits and solutions as global demand rises. Rapid oral fluid screening device start-ups are also stepping into the competitive landscape with their unique rapid oral fluid screening equipment which aids in solving key issues such as drug driving and substance abuse.

• Bloonics B.V., a start-up developing diagnostic solutions for the detection of activity, has developed a new technology that is claimed to measure impairment levels more accurately. The LuciX technology was expected to estimate when the person has taken and determine the probability of their impairment at the time of taking the test. This technology could revolutionize roadside drug testing for police and other authorities.

Key Companies Profiled:

• OraSure Technologies Inc.
• MEDACX Ltd.
• Abbott Laboratories
• Oranoxis Inc.
• AccuBioTech Co. Ltd.
• Premier Biotech Inc.
• Guangzhou Wondfo Biotech Co. Ltd.
• UCP Biosciences Inc.
• SCREEN ITALIA SRL
• Securetec Detektions-Systeme AG

For in-depth competitive analysis, Buy Now:

https://www.factmr.com/checkout/2694

Rapid Oral Fluid Screening Devices Industry Research Segmentation

• By Drug Type :

o Alcohol
o Marijuana
o Opioids
o Amphetamines
o Methamphetamines
o Benzodiazepines
o Others

• By Form :

o Cassettes
o Swabs
o Strips

Key Questions Covered in the Rapid Oral Fluid Screening Devices Market Report:

• What is the projected value of the Rapid Oral Fluid Screening Devices factors Industry in 2023?
• At what rate will the global Rapid Oral Fluid Screening Devices factors market size grow until 2033?
• Which are the factors hampering the growth of Rapid Oral Fluid Screening Devices factors?
• Which region is expected to lead in the global Rapid Oral Fluid Screening Devices factors market by 2033?
• Which are the factors driving the Rapid Oral Fluid Screening Devices factors Industry during the forecast period?
• What is the expected market value of the Rapid Oral Fluid Screening Devices factors market during the forecast period?

Regional Analysis for Rapid Oral Fluid Screening Devices Market:

• APAC (Japan, China, South Korea, Australia, India, and the rest of APAC; the rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (USA, Canada and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Saudi Arabia, United Arab Emirates, South Africa)

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of industry research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.